Shares of (NYSE: ABBV) were bouncing along merrily for most of Thursday's trading session, until news of a fresh demand from the White House quashed the rally. Initially, the market was cheered by better-than-expected quarterly results published by the company that morning. Ultimately AbbVie's stock closed down slightly lower in price, roughly mirroring the trajectory of the S 500 index.
That late-session swoon was kind of a shame, because AbbVie's second quarter boasted some good fundamentals.
Image source: Getty Images.
Source Fool.com